Sofinnova Capital Vi Fcpr - Net Worth and Insider Trading

Sofinnova Capital Vi Fcpr Net Worth

The estimated net worth of Sofinnova Capital Vi Fcpr is at least $2 Million dollars as of 2024-05-12. Sofinnova Capital Vi Fcpr is the 10% Owner of HOOKIPA Pharma Inc and owns about 3,177,574 shares of HOOKIPA Pharma Inc (HOOK) stock worth over $2 Million. Details can be seen in Sofinnova Capital Vi Fcpr's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sofinnova Capital Vi Fcpr has not made any transactions after 2021-04-21 and currently still holds the listed stock(s).

Transaction Summary of Sofinnova Capital Vi Fcpr

To

Sofinnova Capital Vi Fcpr Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sofinnova Capital Vi Fcpr owns 2 companies in total, including HOOKIPA Pharma Inc (HOOK) , and BioAmber Inc (BIOA.U) .

Click here to see the complete history of Sofinnova Capital Vi Fcpr’s form 4 insider trades.

Insider Ownership Summary of Sofinnova Capital Vi Fcpr

Ticker Comapny Transaction Date Type of Owner
HOOK HOOKIPA Pharma Inc 2021-04-21 10 percent owner
BIOA.U BioAmber Inc 2013-05-14 10 percent owner

Sofinnova Capital Vi Fcpr Latest Holdings Summary

Sofinnova Capital Vi Fcpr currently owns a total of 1 stock. Sofinnova Capital Vi Fcpr owns 3,177,574 shares of HOOKIPA Pharma Inc (HOOK) as of April 21, 2021, with a value of $2 Million.

Latest Holdings of Sofinnova Capital Vi Fcpr

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HOOK HOOKIPA Pharma Inc 2021-04-21 3,177,574 0.77 2,440,377

Holding Weightings of Sofinnova Capital Vi Fcpr


Sofinnova Capital Vi Fcpr Form 4 Trading Tracker

According to the SEC Form 4 filings, Sofinnova Capital Vi Fcpr has made a total of 14 transactions in HOOKIPA Pharma Inc (HOOK) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in HOOKIPA Pharma Inc is the sale of 328,620 shares on April 21, 2021, which brought Sofinnova Capital Vi Fcpr around $4 Million.

Insider Trading History of Sofinnova Capital Vi Fcpr

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sofinnova Capital Vi Fcpr Trading Performance

GuruFocus tracks the stock performance after each of Sofinnova Capital Vi Fcpr's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sofinnova Capital Vi Fcpr is -50.69%. GuruFocus also compares Sofinnova Capital Vi Fcpr's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sofinnova Capital Vi Fcpr within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sofinnova Capital Vi Fcpr's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sofinnova Capital Vi Fcpr

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -32.65
Relative Return to S&P 500(%) -28.85

Sofinnova Capital Vi Fcpr Ownership Network

Ownership Network List of Sofinnova Capital Vi Fcpr

No Data

Ownership Network Relation of Sofinnova Capital Vi Fcpr


Sofinnova Capital Vi Fcpr Owned Company Details

What does HOOKIPA Pharma Inc do?

Who are the key executives at HOOKIPA Pharma Inc?

Sofinnova Capital Vi Fcpr is the 10 percent owner of HOOKIPA Pharma Inc. Other key executives at HOOKIPA Pharma Inc include director & Chief Financial Officer Reinhard Kandera , director & Chief Executive Officer Jorn Aldag , and Chief Medical Officer Katia Schlienger .

HOOKIPA Pharma Inc (HOOK) Insider Trades Summary

Over the past 18 months, Sofinnova Capital Vi Fcpr made no insider transaction in HOOKIPA Pharma Inc (HOOK). Other recent insider transactions involving HOOKIPA Pharma Inc (HOOK) include a net purchase of 27,000 shares made by Reinhard Kandera , and a net purchase of 20,000 shares made by Jorn Aldag .

In summary, during the past 3 months, insiders sold 0 shares of HOOKIPA Pharma Inc (HOOK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of HOOKIPA Pharma Inc (HOOK) were sold and 47,000 shares were bought by its insiders, resulting in a net purchase of 47,000 shares.

HOOKIPA Pharma Inc (HOOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

HOOKIPA Pharma Inc Insider Transactions

No Available Data

Sofinnova Capital Vi Fcpr Mailing Address

Above is the net worth, insider trading, and ownership report for Sofinnova Capital Vi Fcpr. You might contact Sofinnova Capital Vi Fcpr via mailing address: C/o Sofinnova Partners, 17 Rue De Surene, Paris Xx 75008.

Discussions on Sofinnova Capital Vi Fcpr

No discussions yet.